1. Inicio
  2. Proyectos y Estudios
  3. CONTRATO POST FSE (RIO HORTEGA)

CONTRATO POST FSE (RIO HORTEGA)

Datos básicos

Protocolo:
CM13/00022
EUDRACT:
NCT:
Centro:
Año de incio:
2014
Año de finalización:
2016
RRHH NACIONAL Finan. Competitiva Pública 71.080,00 €

Objetivos del proyecto

FAVORABLE

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA
INSTITUTO DE SALUD CARLOS III

Resultados del Ensayo Clínico

Current knowledge of genetic risk factors for venous thrombosis

SILVIA NAVARRO ROSALES; (...); PILAR MEDINA BADENES

Capítulo de un Libro. 2014


349 - Clinical usefulness of eight novel monoclonal antibodies against prostate-specific antigen (PSA) to differentiate prostate cancer and benign prostate hyperplasia. Measurement of different PSA molecular forms with specific immunoassays

S. Navarro; (...); P. Medina-Badenes

Article. 10.1016/S1569-9056(17)30413-X. 2017

  • Open Access.

A MODIFICATION OF CALIBRATED AUTOMATED THROMBIN GENERATION ASSAY TO EXPLORE NEW COFACTORS OF ACTIVATED PROTEIN C IN PLASMA

Martos, L.; (...); Navarro Rosales, S.

Meeting Abstract. 10.1016/S0049-3848(14)50233-2. 2014


A NOVEL TISSUE MICRORNA SIGNATURE FOR ARRHYTHMOGENIC CARDIOMYOPATHY

Zorio, E.; (...); Medina, P.

Article. 10.1016/S0049-3848(14)50269-1. 2014


A predictive model for prostate cancer incorporating PSA molecular forms and age.

Oto J; (...); Navarro S

Article. 10.1038/s41598-020-58836-4. 2020

  • Open Access.

A simplified assay for the quantification of circulating activated protein C

Martos L; (...); Medina P

Article. 10.1016/j.cca.2016.05.025. 2016


a2-Macroglobulin is a significant in vivo inhibitor of activated protein C and low levels of APC:a2M are associated with venous thromboembolism

Navarro S; (...); Medina P

Article. 2018


Activated protein C assays: a review.

Oto J; (...); Medina P

Review. 10.1016/j.cca.2019.11.005. 2020


alpha(2)-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC: alpha M-2 Levels Are Associated with Venous Thromboembolism

Martos, L; (...); Medina, P

Article. 10.1055/s-0038-1629902. 2018

  • Open Access.

Circulating Cell-Free DNA in Liquid Biopsies as Potential Biomarker for Bladder Cancer: A Systematic Review

Herranz, R; (...); Medina, P

Review. 10.3390/cancers13061448. 2021

  • Open Access.

COMBINED DEFICIENCY OF PROTEIN C, PROTEIN S AND ANTITHROMBIN IN PATIENTS WITH MESENTERIC OR PORTAL VENOUS THROMBOSIS WITH OR WITHOUT HEPATIC CIRRHOSIS

Martos, L.; (...); Espana, F.

Meeting Abstract. 10.1016/S0049-3848(14)50197-1. 2014


Comparison of protocols and RNA carriers for plasma miRNA isolation. Unraveling RNA carrier influence on miRNA isolation

Ramon-Nunez, Luis A.; (...); Navarro, Silvia

Article. 10.1371/journal.pone.0187005. 2017

  • Open Access.

Functional Analysis of Two Haplotypes of the Human Endothelial Protein C Receptor Gene

Medina P; (...); España F

Article. 10.1161/ATVBAHA.113.302518. 2014


FUNCTIONAL ANALYSIS OF TWO HAPLOTYPES OF THE HUMAN ENDOTHELIAL PROTEIN C RECEPTOR GENE (PROCR)

Bonet, E.; (...); Navarro Rosales, S.

Meeting Abstract. 10.1016/S0049-3848(14)50053-9. 2014


Identification and validation of plasma micrornas involved in venous and arterial thrombosis

Ramon, L. A.; (...); Navarro, S.

Meeting Abstract. 2015


IDENTIFICATION OF 58 MUTATIONS (26 NEW) IN 94 OF 109 BEING TESTED WITH PROTEIN DEFICIENCY C. SETH WORKING GROUP

Fernandez-Pardo, A.; (...); Navarro, S.

Meeting Abstract. 2019

  • Open Access.

Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

Martos, L; (...); Spanish Soc Thrombosis Haemostasis

Article. 10.1055/s-0039-1692440. 2019


IDENTIFICATION OF 6 MUTATIONS IN THE PROTEIN C GENE (PROC) IN A PANEL OF 83 SPANISH FAMILIES WITH PROTEIN C DEFICIENCY

Martos, L.; (...); Espana, F.

Meeting Abstract. 10.1016/S0049-3848(14)50254-X. 2014


IDENTIFICATION OF A MICRORNA PROFILE RELATED TO HYPERTROPHIC CARDIOMYOPATHY

Plana, E.; (...); Medina, P.

Meeting Abstract. 10.1016/S0049-3848(14)50064-3. 2014


IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN ARTERIAL THROMBOSIS

Navarro, S.; (...); Espana, F.

Meeting Abstract. 10.1016/S0049-3848(14)50273-3. 2014


IDENTIFICATION OF A PLASMA MICRORNAS PROFILE INVOLVED IN VENOUS THROMBOSIS

Navarro, S.; (...); Espana, F.

Meeting Abstract. 10.1016/S0049-3848(14)50271-X. 2014


IDENTIFICATION OF A PROFILE OF CLASSES OF CIRCULATING LIPIDS ASSOCIATED WITH THE VENOUS THROMBOEMBOLISM

Fernandez-Pardo, A.; (...); Navarro, S.

Meeting Abstract. 2019

  • Open Access.

Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.

Oto J; (...); Medina P

Article. 10.3390/biomedicines8110447. 2020

  • Open Access.

In silico validation of serum protein profile in long- and short-term glioblastoma survivors: A proteomic approach to prognostic factors

Bruixola, G.; (...); Reynes, G.

Meeting Abstract. 10.1016/S0959-8049(16)31646-X. 2015


Increase of Neutrophil Activation Markers in Venous Thrombosis-Contribution of Circulating Activated Protein C

Martos L; (...); Medina P

Article. 10.3390/ijms21165651. 2020

  • Open Access.

Increased circulating dna, calprotectin and mieloperoxidase, as neutrophil extracellular trap markers, are risk factors for deep vein thrombosis

Martos, L.; (...); Medina, P.

Meeting Abstract. 2015


INCREASED LEVELS OF FREE CIRCULATING DNA AND DNASE 1 ACTIVITY IN PLASMA IS ASSOCIATED WITH AN INCREASED RISK OF VENOUS THROMBOEMBOLISM

Oto, J.; (...); Medina, P.

Meeting Abstract. 2019

  • Open Access.

Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.

Deguchi, H; (...); Griffin, JH

Article. 10.1002/rth2.12018. 2017

  • Open Access.

MicroRNA expression profile in endometriosis: its relation to angiogenesis and fibrinolytic factors

Braza-Boïls A; (...); Estellés A

Article. 10.1093/humrep/deu019. 2014


microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors

Oto, J; (...); Medina, P

Article. 10.3390/cancers12061536. 2020

  • Open Access.

MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma.

Oto J; (...); Medina P

Article. 10.3390/ijms21030840. 2020

  • Open Access.

Modification of a thrombin generation test to identify new cofactors of the protein C pathway in plasma

Martos, L.; (...); Navarro, S.

Meeting Abstract. 2015


PLASMATIC DNA STIMULATES THE GENERATION OF IN VITRO THROMBIN EVEN IN THE ABSENCE OF EXTRINSIC TISSUE FACTOR AND CAN BE REVERSED WITH DNA'S

Fernandez-Pardo, A.; (...); Medina, P.

Meeting Abstract. 2019

  • Open Access.

Quantitative immunoassay for the measurement of activated protein C complexes with Alfa-2-macroglobulin (APC:alpha M-2)

Espana, F.; (...); Medina, P.

Meeting Abstract. 2015


Red Blood Cell Distribution Width in Patients With Cryptogenic Stroke

Vayá A; (...); Bautista D

Article. 10.1177/1076029614547262. 2015


Single-Nucleotide Polymorphism Array-Based Karyotyping of Acute Promyelocytic Leukemia

Gómez-Seguí I; (...); Sanz MA

Article. 10.1371/journal.pone.0100245. 2014

  • Open Access.

Urinary microRNAs: Looking for a New Tool in Diagnosis, Prognosis, and Monitoring of Renal Cancer

Oto, J; (...); Medina, P

Article. 10.1007/s11934-020-0962-9. 2020


Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study

Oto J; (...); Medina P

Article. 10.1016/j.jprot.2020.103723. 2020


VALIDATION OF A MODEL WITH COAGULATION-RELATED MARKERS FOR THE DIAGNOSIS OF PROSTHETIC JOINT INFECTION

Oto, J.; (...); Medina, P.

Meeting Abstract. 2019

  • Open Access.

Campos de Estudio

Compartir